PreveCeutical Medical Inc.
PRVCF
$0.02
$0.002.37%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -124.30% | -100.03% | -45.40% | 9.03% | -158.04% |
| Total Depreciation and Amortization | 28.38% | 20.55% | 5.48% | 2.78% | -27.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 189.95% | 183.68% | 37.89% | -11.90% | 427.79% |
| Change in Net Operating Assets | 26.40% | 18.57% | 35.22% | -35.40% | 42.48% |
| Cash from Operations | -209.42% | -146.71% | -76.68% | -41.44% | -1,071.89% |
| Capital Expenditure | -225.00% | -285.71% | -16.67% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -1,766.67% | -- | -- |
| Cash from Investing | -237.50% | -5,957.14% | -2,361.11% | -- | -- |
| Total Debt Issued | -69.90% | -64.92% | 26.24% | 9.77% | -21.61% |
| Total Debt Repaid | -36.30% | 3.06% | -- | -- | -- |
| Issuance of Common Stock | 617.72% | 724.57% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 242.21% | 164.78% | 104.72% | 63.16% | 12.10% |
| Foreign Exchange rate Adjustments | -1,591.67% | 65.00% | -- | -83.33% | 99.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7,009.09% | 323.53% | 212.00% | 1,387.50% | -57.14% |